Murae Organiser hit the 5% upper circuit after securing ₹297 crore in supply orders. The Board will meet on June 13 to discuss a potential 100% dividend, a bonus issue, and business expansion.
On Monday, the share price of Murae Organiser locked in the 5% upper circuit as the company announced that it had secured a supply order, and the Board of Directors will convene a meeting on Thursday, June 13, 2025. The stock witnessed a back-to-back upper circuit in the last 11 trading sessions.
Murae Organiser Limited (formerly known as Earum Pharmaceuticals Limited) has successfully secured supply orders worth up to ₹297 Crores from various domestic institutional clients in the FMCG, agri-processing, and commodity trade sectors. These orders include essential agricultural commodities such as mustard seeds, groundnuts, chickpeas, and other oilseeds and pulses.
The company plans to execute these orders in phases, with an initial tranche of approximately ₹57 Crores scheduled for execution within the next 30 days. This strategic move aims to achieve scale-based growth, improve operating leverage, and establish recurring commodity contracts, contributing meaningfully to revenue momentum in the coming quarters and positioning Murae as a reliable institutional-grade commodity partner.
The company has announced that its Board of Directors will convene a meeting on Thursday, June 13, 2025, at the company's registered office. The key agenda items for discussion include the potential declaration of a dividend of up to 100% of the face value of equity shares for the financial year ended March 31, 2025.
In addition to the dividend proposal, the Board will also consider and approve a bonus issue of equity shares to the company's shareholders. Furthermore, the board will discuss strategic business expansion proposals, including capital deployment for both proposed and ongoing projects within the agro and distillery sectors.
The Board of Directors, in a meeting held on May 30, 2025, approved a stock split in the ratio of 1:2, subdividing one equity share of face value ₹2 into two shares of ₹1 each. The record date for this sub-division has been fixed as June 11, 2025, following shareholder approval via postal ballot on May 29, 2025.
Established in 2012, the company provides a comprehensive portfolio across multiple therapeutic segments, including dermatology, neurology, steroids, gynaecology, and injectable products.
Track the Murae Organiser stock price today to stay updated with the latest market trends.
Disclaimer: The article is for informational purposes only and not investment advice.
For android only